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Hepatitis B core antigen (HBcAg) expressed intracellularly in Escherichia coli (E. 
coli) has great potential and high demand in pharmaceutical market. The main 
objective of this study was to develop an efficient and cost effective protocol for the 
recovery of recombinant HBcAg. Cell disruption is the prerequisite step to release 
the intracellular HBcAg to the surrounding medium prior to subsequent purification 
processes. In the current study, E. coli was disrupted by mechanical method of bead 
milling. Bead milling can be operated either in batch or continuous recycling mode. 
The performance of bead milling is affected by parameters such as impeller tip 
speed, biomass concentration, bead loading and feed flow rate. Thus, in the first 
chapter of the study, the effects of these parameters on different modes of operation 
were investigated. The effect of these operation modes on the subsequent 
downstream processing was also examined. In the second chapter of the study, a 
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purification protocol for the recovery of HBcAg was developed. The HBcAg was 
initially purified by the integrated operation of batch mode bead milling and 
expanded bed adsorption (EBA), and subsequently purified by size exclusion 
chromatography (SEC). 
 
The results of the cell disruption study show that the optimum disruption of E. coli 
and release of intracellular HBcAg in batch mode bead milling was achieved at 
impeller tip speed of 14 m/s, biomass concentration of 20% (w/v) and bead loading 
of 80% (v/v), whilst the performance of continuous recycling bead milling was peak 
at impeller tip speed of 14 m/s, biomass concentration of 10% (w/v) and feed flow 
rate of 15 L/h. Batch mode was ideal for the batch anion-exchange adsorption, in 
which a HBcAg yield of 34.3%, a HBcAg purity of 65% and a purification factor of 
2.86 was achieved.  
 
In the purification study, the product yield, product purity and purification factor 
achieved in the integrated EBA process was 55%, 42.3% and 1.96, respectively. The 
partially purified HBcAg was then further purified by SEC, in which a product yield 
of 42.4% was obtained. The SEC purification has also yielded a HBcAg purity of 
88.2%, which corresponded to a purification factor of 4.08. The purified HBcAg was 
confirmed to be functionally active and hence, can be used in the development of 
hepatitis B virus (HBV) diagnostic kits.  
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Mei 2007 
 
Pengerusi: Professor Madya Tey Beng Ti, PhD 
Fakulti: Kejuruteraan 
 
Hepatitis B core antigen (HBcAg) yang diekspresi secara intrasel dalam Escherichia 
coli (E. coli) mempunyai potensi dan permintaan yang tinngi dalam pasaran 
farmaseutik. Objektif utama kajian ini ialah membangunkan satu protokol yang 
cekap dan kos-berkesan untuk pemulihan HBcAg rekombinan. Pemecahan sel ialah 
langkah pertama untuk membebaskan HBcAg intrasel ke medium sekeliling sebelum 
proses penulenan berikutnya. Dalam kajian ini, E. coli dipecahkan oleh kaedah 
mekanikal pengisaran manik. Pengisaran manik boleh dioperasi sama ada dengan 
mod kelompok atau mod berkitar berterusan. Prestasi pengisaran manik adalah 
dipengaruhi oleh parameter seperti kelajuan hujung pendesak, kepekatan biojisim, 
pengisian manik dan kadar aliran suapan. Oleh itu, dalam bab pertama kajian ini, 
kesan parameter-parameter ini terhadap mod operasi yang berlainan telah disiasat. 
Kesan mod pengisaran manik terhadap proses hiliran berikutan juga telah diperiksa. 
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Dalam bab kedua kajian ini, satu protokol penulenan bagi pemulihan HBcAg telah 
dibangunkan. HBcAg pada awalnya ditulenkan oleh operasi berintegrasi antara 
pengisaran manik mod kelompok dan penjerapan lapisan terkembang (EBA), dan 
kemudiannya ditulenkan oleh komatografi penyisihan saiz (SEC). 
 
Keputusan kajian pemecahan sel menunjukkan bahawa pemecahan sel E. coli dan 
pembebasan HBcAg intrasel yang optimum dengan pengisaran manik mod kelompok 
telah dicapai pada kelajuan hujung pendesak selaju 14 m/s, kepekatan biojisim 
sebanyak 20% (w/v) dan pengisian manik sebanyak 80% (v/v), sementara 
persembahan pengisaran manik berkitar berterusan adalah kemuncak pada kelajuan 
hujung pendesak selaju 14 m/s, kepekatan biojisim sebanyak 10% (w/v) dan kadar 
aliran suapan bernilai 15 L/j. Kesan mod pengisaran manik terhadap proses hiliran 
berikutan juga telah diperiksa. Mod kelompok adalah ideal untuk penjerapan 
kelompok pertukaran anion, dalam mana hasil HBcAg setinggi 34.3%, ketulenan 
HBcAg setinggi 65% dan faktor penulenan setinggi  2.86 telah dicapai.  
 
Dalam kajian penulenan, hasil produk, ketulenan poduk dan faktor penulenan yang 
dicapai dalam proses berintegrasi EBA adalah masing-masing setinggi 55%, 42.3% 
dan 1.96. HBcAg separa tulen kemudiannya ditulenkan lagi dengan SEC, dalam 
mana hasil produk setinggi 42.4% telan diperolehi. Proses penulenan SEC juga 
menghasilkan ketulenan produk sebanyak 88.2%, yang mana selaras dengan faktor 
penulenan sebanyak 4.08. HBcAg yang ditulenkan telah disahkan berfungsi secara 
aktif dan boleh digunakan dalam pembangunan kit diagnostik virus hepatitis B 
(HBV). 
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CHAPTER 1 
 
 INTRODUCTION 
 
Biotechnology is a highly multidisciplinary field and has its foundations in biology, 
microbiology, biochemistry, molecular biology, genetics, chemistry, and chemical 
and process engineering (Smith, 2004). In the twentieth century, modern 
biotechnology has generated a wide range of new and novel products, such as nucleic 
acid-based products and therapeutic proteins. By mid-2003, some 118 nucleic acid-
based products and therapeutic proteins (produced by genetic engineering and 
hybridoma technology) have gained marketing approval and one in four genuinely 
new drugs on the market are now produced by biotechnological means (Spada and 
Walsh, 2005). In the industrial manufacturing of these products, downstream 
processing (DSP) is economically vital. DSP is the general term used to describe the 
separation processes used to recover biological products (Liddel, 1994). Some of 
these products are intracellular and have to be released to the surrounding prior to 
subsequent DSP. This is achieved by cell disruption. Cell disruption is closely 
connected to the performance of subsequent DSP due to its effects on the quality (eg. 
purity, concentration, molarity and amount of cell debris) and physical conditions 
(eg. viscosity, conductivity, density) of the cell disruptate derived. 
 
The common cell disruption methods include ultrasonication and enzymatic 
(Harison, 1991; Garcia, 1993; Middelberg, 1995). These two methods are usually 
utilized in laboratory scale operation and are not suitable for large-scale disruption 
(Geciova et al., 2002). Another popular cell disruption technique is bead milling. In 
bead milling, the cells are agitated in suspension with small abrasive particles such as 
glass beads, silica, or sands. Cell walls are ruptured by shear forces of the grinding 
action of rotating beads and from the impact resulting from collision with cascading 
beads. Bead milling can be operated either in batch or continuous mode. Bead 
milling is widely used for large-scale cell disruption due to its relatively low power 
consumption and capability to process large volume of biomass (Garcia, 1993; 
Middelberg, 1995). 
  
A suitable DSP is required to purify and isolate the intracellular product released 
during cell disruption. Ion exchange adsorption chromatography is a widely used 
DSP unit operation for primary capture of proteins and other charged biomolecules 
(Bonnerjea et al., 1986). Ion exchange chromatography can be subdivided into cation 
and anion exchange chromatography. In cation exchange chromatography, positively 
charged ions are bound to negatively charged adsorbents, whilst negatively charged 
ions are attracted to positively charged resins in anion exchange chromatography. Ion 
exchange chromatography can be operated either batchwise or in expanded bed 
adsorption (EBA) mode (Amersham 2004a; Amersham 2004b). 
 
The target protein used in the current study is a recombinant hepatitis B core antigen 
(HBcAg) that was expressed in Escherichia coli (E. coli). HBcAg plays an important 
role in diagnosis and monitoring of hepatitis B infection. It is widely used as antigen 
for the detection of anti-HBcAg antibodies in serum samples (Hoofnagle et al., 1974; 
Korec et al., 1989; Tordjeman et al., 1992). It assembles into virus like particle 
(VLP), which has been widely used to display immunodominant epitopes of various 
virus such as hepatitis B, C and E, Hanta, foot-and-mouth, influenza, human 
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immunodeficiency virus and other viral proteins (Pumpens and Grens, 2001). Due to 
the vast potential and high demand of HBcAg in the pharmaceutical market, there is 
a need to produce this intracellular protein in large scale. Hence, the primary aim of 
this study was to develop an efficient and cost effective protocol for the production 
of recombinant HBcAg. In the current study, the cell disruption of E. coli expressing 
recombinant HBcAg was achieved by bead milling. The expression level of this 
protein in E. coli was about 20-25% of the total host protein, which is considered 
high. Furthermore, this protein has a pI (iso-electric point) of 4 and therefore has a 
negative net charge at pH 8.4. Thus, it can be purified using anion exchange 
chromatography. The combination of bead milling and anion exchange would result 
in a fast, simple, efficient and relatively cheap HBcAg production process. 
Therefore, the objectives of the current study were: 
 
1. To optimize the operating conditions of both batch and continuous recycling 
mode of bead milling and to investigate the effects of these operation modes on 
the performance of batch anion-exchange adsorption chromatography. 
2. To develop a protocol for HBcAg purification by utilizing integrated EBA 
procedure and size-exclusion chromatography (SEC). 
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CHAPTER 2 
 
 LITERATURE REVIEW 
 
2.1 Hepatitis B 
 
Hepatitis B is a worldwide public health problem. The causative agent of this B-type 
hepatitis in human is hepatitis B virus (HBV). It belongs to the virus family 
Hepadnaviridae (Seeger and Mason, 2000). The number of HBV carriers worldwide 
is estimated to be 2 billion, of which about 360 million are chronically infected 
(WHO, 2004).  Most individuals who contracted Hepatitis B infection have a mild or 
entirely symptom-free disease that disappears by itself and requires no medical 
treatment. It leaves the affected person with lifelong immunity against hepatitis B. 
However, the remaining infected individuals will develop chronic HBV infection that 
may lead to liver cirrhosis and heptocellular carcinoma (HCC), which resulted in 
about 500-700 thousand deaths per year worldwide (WHO, 2004). 
 
2.1.1 Hepatitis B Virus (HBV) 
 
HBV has been divided into 6 genotypes: A to F, by the comparison of its complete 
nucleotide sequences (Norder et al., 1992, Norder et al., 1994, Kramvis et al., 2005). 
The genotypes show a distinct geographical distribution between and even within 
regions, and are proving to be an invaluable tool in tracing the molecular evolution 
and patterns and modes of spread of hepatitis B virus (Kramvis et al., 2005). 
Structural HBV serotypes and genotypes are not uniformly distributed around the 
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